Clinical survival data suggest that TUBB3 expression correlates with poor prognosis in bladder cancer patients, indicating that ALDH1A1 and TUBB3 may serve as promising therapeutic targets.24 The gene discussed is ALDH1A1; the disease is urinary bladder carcinoma.